215 related articles for article (PubMed ID: 35716767)
1. The myosin II inhibitor, blebbistatin, ameliorates pulmonary endothelial barrier dysfunction in acute lung injury induced by LPS via NMMHC IIA/Wnt5a/β-catenin pathway.
Zhang J; Pan Z; Zhou J; Zhang L; Tang J; Gong S; Li F; Yu B; Zhang Y; Kou J
Toxicol Appl Pharmacol; 2022 Sep; 450():116132. PubMed ID: 35716767
[TBL] [Abstract][Full Text] [Related]
2. Ruscogenin alleviates LPS-induced pulmonary endothelial cell apoptosis by suppressing TLR4 signaling.
Wu Y; Wang Y; Gong S; Tang J; Zhang J; Li F; Yu B; Zhang Y; Kou J
Biomed Pharmacother; 2020 May; 125():109868. PubMed ID: 32036210
[TBL] [Abstract][Full Text] [Related]
3. Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling.
Wu Y; Yu X; Wang Y; Huang Y; Tang J; Gong S; Jiang S; Xia Y; Li F; Yu B; Zhang Y; Kou J
Acta Pharm Sin B; 2022 Mar; 12(3):1198-1212. PubMed ID: 35530141
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin-induced acute lung injury.
Kovacs-Kasa A; Kovacs L; Cherian-Shaw M; Patel V; Meadows ML; Fulton DJ; Su Y; Verin AD
J Cell Physiol; 2021 Apr; 236(4):2893-2905. PubMed ID: 32959895
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid synthase protects obese mice from acute lung injury via ameliorating lung endothelial dysfunction.
Wu Z; Zhu L; Nie X; Liu Y; Zhang X; Qi Y
Respir Res; 2023 Mar; 24(1):81. PubMed ID: 36922854
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury.
Gong S; Cao G; Li F; Chen Z; Pan X; Ma H; Zhang Y; Yu B; Kou J
Stroke; 2021 Mar; 52(3):1053-1064. PubMed ID: 33588591
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury.
Gonzales JN; Gorshkov B; Varn MN; Zemskova MA; Zemskov EA; Sridhar S; Lucas R; Verin AD
Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L497-507. PubMed ID: 24414256
[TBL] [Abstract][Full Text] [Related]
8. The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1/AKT pathway.
Zhang N; Tang S; Zhang J; Pei B; Pang T; Sun G
Biomed Pharmacother; 2022 Nov; 155():113704. PubMed ID: 36115114
[TBL] [Abstract][Full Text] [Related]
9. NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signalling pathways in the endothelium.
Zhai K; Tang Y; Zhang Y; Li F; Wang Y; Cao Z; Yu J; Kou J; Yu B
Thromb Haemost; 2015 Jul; 114(1):173-85. PubMed ID: 25881103
[TBL] [Abstract][Full Text] [Related]
10. HSPA12A improves endothelial integrity to attenuate lung injury during endotoxemia through activating ERKs and Akt-dependent signaling.
Dai Y; Liu J; Zhang X; Min X; Wu J; Du S; Li T; Liu L; Ding Z
Int Immunopharmacol; 2021 Oct; 99():107987. PubMed ID: 34343936
[TBL] [Abstract][Full Text] [Related]
11. Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury.
Mu S; Liu Y; Jiang J; Ding R; Li X; Li X; Ma X
Respir Res; 2018 Nov; 19(1):220. PubMed ID: 30442128
[TBL] [Abstract][Full Text] [Related]
12. PLD2 deficiency alleviates endothelial glycocalyx degradation in LPS-induced ARDS/ALI.
Kong G; Li D; Liu X; Feng J; Ning F; Huang X; Qi B; Qu J; Wang X
Biochem Biophys Res Commun; 2024 Jul; 716():150019. PubMed ID: 38703555
[TBL] [Abstract][Full Text] [Related]
13. GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury.
Yi L; Huang X; Guo F; Zhou Z; Chang M; Huan J
Front Cell Infect Microbiol; 2017; 7():357. PubMed ID: 28824887
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of high mobility group protein B1 in lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome].
Qu J; Feng J; Li J; Huang X; Qi B; Qian T; Wang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Aug; 34(8):825-830. PubMed ID: 36177925
[TBL] [Abstract][Full Text] [Related]
15. Myosin IIA Regulated Tight Junction in Oxygen Glucose-Deprived Brain Endothelial Cells Via Activation of TLR4/PI3K/Akt/JNK1/2/14-3-3ε/NF-κB/MMP9 Signal Transduction Pathway.
Lv Y; Liu W; Ruan Z; Xu Z; Fu L
Cell Mol Neurobiol; 2019 Mar; 39(2):301-319. PubMed ID: 30666520
[TBL] [Abstract][Full Text] [Related]
16. Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS).
Shah D; Das P; Acharya S; Agarwal B; Christensen DJ; Robertson SM; Bhandari V
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806560
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury.
Lee EH; Shin MH; Gi M; Park J; Song D; Hyun YM; Ryu JH; Seong JK; Jeon Y; Han G; Namkung W; Park MS; Choi JY
Theranostics; 2020; 10(22):9913-9922. PubMed ID: 32929324
[No Abstract] [Full Text] [Related]
18. Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome.
Luo Y; Ge S; Chen Q; Lin S; He W; Zeng M
Stem Cell Res Ther; 2023 Feb; 14(1):27. PubMed ID: 36788588
[TBL] [Abstract][Full Text] [Related]
19. APELIN-13 AMELIORATES LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION AND POST-ACUTE LUNG INJURY PULMONARY FIBROSIS BY SUPPRESSING TRANSFORMING GROWTH FACTOR-Β1 SIGNALING.
Liu H; Shi Q; Tang L; Wang H; Wang D
Shock; 2023 Jan; 59(1):108-117. PubMed ID: 36377383
[TBL] [Abstract][Full Text] [Related]
20. Calpain Promotes LPS-induced Lung Endothelial Barrier Dysfunction via Cleavage of Talin.
Song L; Shi X; Kovacs L; Han W; John J; Barman SA; Dong Z; Lucas R; Fulton DJR; Verin AD; Su Y
Am J Respir Cell Mol Biol; 2023 Dec; 69(6):678-688. PubMed ID: 37639326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
